StartseiteMCPWorkbenchSkills
StartseiteWorkbenchBenachrichtigungenMein Bereich
llms.txt · MCP-AnleitungDatenschutz · Nutzungsbedingungen · Supportv1.8.3
  1. Startseite
  2. /Verbindung

Ropinirole Hydrochloride

HCID 68727
Neue Reaktion
Drucken
GrundinformationenÜberblickNamen und BezeichnerEigenschaftenSicherheit und RegulatorischesChemie und IndustrieZugehörige ReaktionenNotizen zur Verbindung
TeilstruktursucheÄhnliche Strukturen suchen

Grundinformationen

CAS
91374-20-8
Standard-SMILES
CCCN(CCC)CCc1cccc2c1CC(=O)N2.Cl
InChIKey
XDXHAEQXIBQUEZ-UHFFFAOYSA-N
Summenformel
C16H25ClN2O
Durchschnittliche Molmasse
296,83 g/mol
Monoisotopische Masse
296,1655411

Überblick

Ropinirole hydrochloride is a member of indoles.

Namen und Bezeichner

Bevorzugter Name
Ropinirole Hydrochloride
IUPAC
4-[2-(dipropylamino)ethyl]-1,3-dihydroindol-2-one;hydrochloride
Englischer Name
Ropinirole hydrochloride
Summenformel
C16H24N2O.ClH
Molmasse
296.84

Namen und Synonyme

Ropinirole hydrochloride91374-20-8Ropinirole HClReQuip XLSK&F 101468-ARopinirole (as hydrochloride)Ropilynz xlAimpart xlIpinnia xlRaponer xlD7ZD41RZI9SK&F-101468-A
Weitere Namen anzeigen
REQUIP4-[2-(Di-n-propylamino)ethyl]-2(3H)-indolone HydrochlorideRequiSKF-101468ASKF-101468 HClRopinirole HCl API(Rac) Hexestrol-d4Ropinirole Hcl ,99%Ropinirole hydrochlo
4-(2-(Dipropylamino)ethyl)-2-indolinone monohydrochlorideDTXCID00161024DTXSID502385332(H)-Indol-2-one, 4-(2-(dipropylamino)ethyl)-1,3-dihydro-, monohydrochloride4-[2-(Dipropylamino)ethyl]-2-indolinone monohydrochlorideRepinex xlSpiroco xlRalnea xl

Datenbank-Bezeichner

CAS
91374-20-8
PubChem CID
68727
DTXSID
DTXSID50238533
ChEMBL

Eigenschaften

Berechnete Struktureigenschaften

Polarare Oberfläche (TPSA)
32,3 Ų
H-Brücken-Donoren
2
H-Brücken-Akzeptoren
2
Frei drehbare Bindungen
7
Schwere Atome
20
Formalladung
0
Komplexität
286

Experimentelle und physikochemische Eigenschaften

Human Drugs · 2 Einträge

FDA approved drugs -> Active ingredient

FDA approved drugs -> Active ingredient

Animal DrugsEMA approved medicines: Veterinary medicine

Physikochemische Eigenschaften

Schmelzpunkt
241 · 241-243°C
storage temp.
2 · 2-8°C
Löslichkeit
2 O: · H2O: >10mg/mL
Aggregatzustand
powder
pka
9.5 · 9.5
Farbe
light yellow
Major Application
pharmaceutical (small molecule)
InChI
InChI=1S/C16H24N2O.ClH/c1-3-9-18(10-4-2)11-8-13-6-5-7-15-14(13)12-16(19)17-15;/h5-7H,3-4,8-12H2,1-2H3,(H,17,19);1H
InChIKey
XDXHAEQXIBQUEZ-UHFFFAOYSA-N
SMILES
C12CC(=O)NC=1C=CC=C2CCN(CCC)CCC.Cl
CAS Datenbank

Sicherheit und Regulatorisches

Sicherheitsangaben dienen nur zur Orientierung und ersetzen weder das Sicherheitsdatenblatt (SDB) des Lieferanten noch geltende Vorschriften oder eine fachliche Bewertung.

GHS-Klassifizierung

GHS Classification · 4 Einträge

Warning

H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral]

P264, P270, P273, P301+P317, P330, P391, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 49 reports by companies from 7 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.

Gefahrenhinweise

Regulatory InformationRopinirole hydrochloride: Does not have an individual approval but may be used as a component in a product covered by a group standard. It is not approved for use as a chemical in its own right.
Hazard Classes and CategoriesAcute Tox. 4 (100%)

Toxikologische Informationen

TreatmentGeneral supportive measures are recommended. Vital signs should be maintained, if necessary. Removal of any unabsorbed material (e.g., by gastric lavage) should be considered. (L1712)
Exposure RoutesOral. Absolute bioavailability is 55%, indicating a first pass effect. Food does not affect the extent of absorption.
Toxicity Summary · 1 Eintrag

Ropinirole binds the dopamine receptors D<sub>3</sub> and D<sub>2</sub>. Although the precise mechanism of action of ropinirole as a treatment for Parkinson's disease is unknown, it is believed to be related to its ability to stimulate these receptors in the striatum. This conclusion is supported by electrophysiologic studies in animals that have demonstrated that ropinirole influences striatal neuronal firing rates via activation of dopamine receptors in the striatum and the substantia nigra, the site of neurons that send projections to the striatum.

Chemie und Industrie

Pharmakologische Informationen

Metabolism/Metabolites · 1 Eintrag

Hepatic. Ropinirole is extensively metabolized to inactive metabolites via N -despropylation and hydroxylation pathways, largely by the P450 isoenzyme CYP1A2. N-despropyl ropinirole is the predominant metabolite found in urine (40%), followed by the carboxylic acid metabolite (10%), and the glucuronide of the hydroxy metabolite (10%). Route of Elimination: Ropinirole is extensively metabolized by the liver to inactive metabolites, and less than 10% of the administered dose is excreted as unchanged drug in urine. Half Life: 6 hours

FDA Pharmacological Classification · 2 Einträge

ROPINIROLE HYDROCHLORIDE

Dopamine Agonists [MoA]; Nonergot Dopamine Agonist [EPC]

MeSH Pharmacological Classification · 2 Einträge

Agents used in the treatment of Parkinson&apos;s disease. The most commonly used drugs act on the dopaminergic system in the striatum and basal ganglia or are centrally acting muscarinic antagonists.

Drugs that bind to and activate dopamine receptors.

Verwendung und Herstellung

UsesFor the treatment of the signs and symptoms of idiopathic Parkinson's disease. Also used for the treatment of restless legs syndrome.
Anwendungen · 2 Einträge

BeschreibungReQuip was launched in the UK as a monotherapy or in combination with low-dose levodopa for the treatment of early-stage idiopathic Parkinson's disease. An eight step (24% overall yield) synthesis from isochroman provides access to ropinirole. It is a non-ergot postsynaptic dopamine D2 agonist with activity in the extrapyramidal system. It has weak or no significant activity at α2-adrenergic, 5-HT2 receptors and is inactive at 5-HT1, benzodiazepine, GABA, α1 and β adrenoreceptors. Thus it has essentially no CNS side effects, fewer dyskinesias and on-off fluctuations. In animals, it was able to reverse all motor deficits induced by MPTP. Tolerance is not developed and ropinirole has similar postsynaptic potency to apomorphine but with significantly less stereotyped behavior.

Zugehörige Reaktionen

5
Reaktionsaufzeichnung erstellen
Reaktionsgleichung von HRID 280270
HRID 280270als Produkt
Reaktionsgleichung von HRID 1262585
HRID 1262585als Produkt
Reaktionsgleichung von HRID 1436851
HRID 1436851als Produkt
Reaktionsgleichung von HRID 1436863
HRID 1436863als Produkt
Reaktionsgleichung von HRID 2224659
HRID 2224659als Edukt

Notizen zur Verbindung

Auf dieser SeiteGrundinformationenÜberblickNamen und BezeichnerEigenschaftenSicherheit und RegulatorischesChemie und IndustrieZugehörige ReaktionenNotizen zur Verbindung
CHEMBL1200411
ChEBI
CHEBI:8889
UNII
D7ZD41RZI9
EC Number
635-615-9
91374 · 91374-20-8(CAS DataBase Reference)
Signs and Symptoms · 1 Eintrag

Symptoms of overdose include agitation, chest pain, confusion, drowsiness, facial muscle movements, grogginess, increased jerkiness of movement, symptoms of low blood pressure (dizziness, light-headedness)upon standing, nausea, and vomiting.

Carcinogen ClassificationNo indication of carcinogenicity to humans (not listed by IARC).
Drug Induced Liver Injury · 6 Einträge

Drug Induced Liver Injury Rank (DILIrank 2.0)

Ropinirole hydrochloride

vLess-DILI-concern

4

Adverse reactions

DOI:10.1016/j.drudis.2016.02.015

Sicherheitsdaten

wgk
3
ridadr
UN 3077 9/PG 3
hs_code
2933790002
RTECS-Nr.
NM3288250
risk_code
22-50/53-36/38
hazard_code
Xn,N,Xi
safety_code
36-60-61-37/39-26
Speicherklasse
11 - Combustible Solids
Hazard Classifications
Acute Tox. 4 OralAquatic Acute 1

VerwendenAn antiparkinsonian agent. A selective dopamine D2-receptor agonist